央视网消息:新的一年,看病用药也有了好消息。国家组织药品集中采购和使用联合采购办公室日前发布全国药品集中采购文件,33个品种入选第二批国家药品集中采购名单,又一波降价药品已经“在路上”。

CCTV net news: the new year, see a doctor medication also have good news. The Office of Centralized Drug Purchase and Use of the State Organization has issued a national centralized drug purchase document,33 varieties have been selected as the second batch of national centralized drug purchase list, and another wave of reduced prices of drugs has been \"on the way.\"

  第二批国家药品集中采购名单涵盖高血压、糖尿病等重大慢性病用药,以及抗肿瘤和罕见病用药。采购目录显示,阿卡波糖等口服降糖药物;奥美沙坦酯等高血压用药;治疗罕见病——肺动脉高压的药物安立生坦片,还有抗癌药替吉奥、阿比特龙等药品入围。

The second batch of national drug centralized purchase list covers hypertension, diabetes and other major chronic diseases, as well as anti-tumor and rare disease drugs. According to the purchase catalogue, acarbose and other oral hypoglycemic drugs; omesartan ester and other hypertension drugs; treatment of rare diseases-pulmonary arterial hypertension drugs anlishengtan tablets, as well as anti-cancer drugs tegeo, abitron and other drugs shortlisted.

  按照集中采购工作安排,2020年1月17日将开标产生拟中选结果,全国各地患者将于今年4月份用上第二批集中带量采购中选药品。

According to the centralized procurement work arrangement, the bid opening will produce the result of the proposed selection on January 17,2020, and patients from all over the country will use the second batch of concentrated belt quantity to purchase the selected drugs in April this year.

  一些未纳入医保目录的自费品种此次也加入集中采购。业内人士指出,这意味着自费药品也将感受到集中带量采购带来的降价“压力”。

Some of the self-financed varieties that are not included in the health care catalogue are also joining the centralized purchase this time. Industry insiders point out that this means that self-financed medicines will also feel the \"pressure\" to reduce prices brought on by concentrated purchases.

  以带量采购的模式引导药品降价,已成为一种趋势。近日,全国5万多家中小型药店组成联盟,通过全国零售药店的销售量和药企谈判,实现“以量换价”,降低药店经营药品的价格。让老百姓吃上便宜的放心药,让药店获得规模和利润双增长,全面助推医药分家实施进程。

It has become a trend to guide the price reduction of drugs by the mode of purchasing with quantity. Recently, more than 50,000 small and medium-sized pharmacies across the country formed an alliance to achieve \"quantity-for-price\" through sales volume of national retail pharmacies and negotiations among pharmaceutical enterprises, and to reduce the price of drugs sold in pharmacies. Let common people take cheap rest assured medicine, let drugstore obtain scale and profit double growth, promote the implementation process of medicine separation in an all-round way.


欢迎转载,转载请注明出处:365网投app下载